BBOX1 Deficiency Exacerbates Liver Fibrosis Through Carnitine Biosynthesis Disruption Rescued by Carnitine Supplementation
Liver International · 2026
DOI: 10.1111/liv.70889 ↗Kurz gefasst
Fachartikel in der Zeitschrift Liver International, 2026. Verfasst von Yuling Zhan und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Science, Bengbu Medical University, Bengbu, China. Hauptthemen laut MEDLINE: Carnitine, gamma-Butyrobetaine Dioxygenase, Liver Cirrhosis. Die Arbeit nennt 47 Literaturangaben. Gefördert von: Science Research Project of Bengbu Medical University, Natural Science Research Project of Anhui Educational Committee, Anhui Provincial Natural Science Foundation.
Abstract (Originalsprache)
Background and Aim Liver fibrosis is a major global health burden with limited treatments. Emerging evidence suggests that metabolic dysregulation can create a state that makes the liver more prone to fibrosis. Carnitine, synthesized by γ‐butyrobetaine hydroxylase (BBOX1), is crucial for fat metabolism, but the role of the BBOX1‐carnitine axis in liver fibrosis is unclear. This study aimed to elucidate the functional impact of BBOX1 deficiency on hepatic fibrogenesis and to delineate the underlying mechanistic pathway.
Methods
We analysed human liver transcriptomic data. Bbox1 knockout (KO) mice and wild‐type (WT) littermates were subjected to thioacetamide (TAA)‐induced liver fibrosis, with or without dietary L‐carnitine supplementation. Comprehensive analyses included metabolomic and transcriptomic profiling, histopathological evaluation, and focused investigation of calcium‐dependent signalling pathways.
Results
BBOX1 expression was significantly downregulated in human cirrhotic livers and correlated with reduced systemic carnitine levels. Bbox1 ‐KO mice exhibited profound hepatic carnitine depletion and a metabolically primed state. With TAA challenge, KO mice developed exacerbated liver fibrosis and inflammation compared to WT controls. This susceptibility was driven by the aberrant activation of the TRPC6‐Ca 2+ /CAMK2B‐inflammatory signalling axis. Moreover, dietary L‐carnitine supplementation completely rescued the aggravated fibrotic phenotype in KO mice.
Conclusion
BBOX1 is a key regulator of liver carnitine metabolism. Its deficiency creates a pro‐fibrotic state by abnormally activating the TRPC6‐Ca 2+ /CAMK2B pathway. Our findings position carnitine as a protector of calcium balance in the liver and identify L‐carnitine supplementation as a potential targeted treatment to slow fibrosis progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Life Science, Bengbu Medical University, Bengbu, China.
- Bengbu Medical University Key Laboratory of Cancer Research and Clinical Laboratory Diagnosis, Bengbu Medical University, Bengbu, China.
- Anhui Key Laboratory of Digital Medicine and Intelligent Health, Bengbu Medical University, Bengbu, China.
- Department of Infectious Diseases, the First Affiliated Hospital of Bengbu Medical University, Bengbu Medical University, Bengbu, China.
- Laboratory Animal Center, Bengbu Medical University, Bengbu, China.
- Anhui Provincial Key Laboratory of Tumor Evolution and Intelligent Diagnosis and Treatment, Bengbu Medical University, Bengbu, China.
ORCID-Profile: Yuling Zhan, Li Zhang, Yu Gao
Förderung
- Science Research Project of Bengbu Medical University
- Natural Science Research Project of Anhui Educational Committee
- Anhui Provincial Natural Science Foundation
- National College Students' Innovative Entrepreneurial Training Plan Program
- Natural Science Foundation of Anhui Province
Zitieren
APA
Zhan, Y., Wang, Y., Wei, T., He, Y., Lu, S., Shao, Q., Ma, S., Zhang, L., Mei, X., & Gao, Y. (2026). BBOX1 Deficiency Exacerbates Liver Fibrosis Through Carnitine Biosynthesis Disruption Rescued by Carnitine Supplementation. Liver International. https://doi.org/10.1111/liv.70889
Vancouver
Zhan Y, Wang Y, Wei T, He Y, Lu S, Shao Q, et al. BBOX1 Deficiency Exacerbates Liver Fibrosis Through Carnitine Biosynthesis Disruption Rescued by Carnitine Supplementation. Liver International. 2026. doi:10.1111/liv.70889
BibTeX
@article{Zhan2026,
author = {Zhan, Yuling and Wang, Ying and Wei, Tianlong and He, Yingyuan and Lu, Shiyi and Shao, Qianqian and Ma, Shasha and Zhang, Li and Mei, Xiaoqiang and Gao, Yu},
title = {BBOX1 Deficiency Exacerbates Liver Fibrosis Through Carnitine Biosynthesis Disruption Rescued by Carnitine Supplementation},
journal = {Liver International},
year = {2026},
doi = {10.1111/liv.70889}
}
EUVIMED